Squarepoint’s Biote Corp BTMD Stock Holding History

Squarepoint’s Portfolio BTMD Stock Details BTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-16,187	Closed	-$48.6K	–	4305
2025 Q3	$48.6K	Buy	+16,187	New	+$57.8K	﹤0.01%	4232
2025 Q1	–	Sell	-18,574	Closed	-$115K	–	4625
2024 Q4	$115K	Buy	+18,574	New	+$108K	﹤0.01%	4662

Other funds holding BTMD

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

Bandera Partners New York $221M AUM 10.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Squarepoint's BTMD Position: Q4 2025 in Review

Squarepoint sold out of Biote Corp (BTMD) in Q4 2025, closing a stake of 16,187 shares — an estimated $48.6K sold.

Squarepoint first reported a position in BTMD in Q4 2024 and held it in 2 quarters. The position peaked at $115K in Q4 2024. 85 funds tracked by Wall St. Rank hold BTMD as of Q4 2025.

Squarepoint reported no remaining Biote Corp position as of Q4 2025 after selling out during the quarter.
Squarepoint sold 16,187 Biote Corp shares in Q4 2025, an estimated $48.6K.
Squarepoint first reported a position in Biote Corp in Q4 2024 and held it in 2 quarters.
Squarepoint's Biote Corp position peaked at $115K in Q4 2024.
85 funds tracked by Wall St. Rank held Biote Corp as of Q4 2025.

Based on Squarepoint's 13F filing for Q4 2025, filed 13 Feb 2026.